RECOMBINANT HUMAN INSULINLIKE GROWTH FACTOR
RECOMBINANT HUMAN INSULINLIKE GROWTH FACTOR
批准号:
6219320
负责人:
BRYAN David MYERS
金额:
$0.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30
关键词:
acute renal failure clinical research confocal scanning microscopy glomerular filtration rate hormone therapy human subject human therapy evaluation hydrostatic pressure insulinlike growth factor kidney function kidney transplantation magnetic resonance imaging membrane permeability recombinant proteins renal ischemia /hypoxia renal tubular transport ultrasound blood flow measurement vasoconstriction
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This proposal seeks to elucidate the pathophysiology of and evaluate novel therapy for postischemic, acute renal failure (ARF) in humans. Delayed function (DF) of a cadaveric renal allograft (Tx) will serve as a prototypic model of ARF. We will examine 140 consecutive Tx recipients of who half are predicted to manifest DF and severe hypofiltration. The remaining half, who will manifest prompt function (PF) and normofiltration will serve as controls. We wish to test four main hypotheses. Hypothesis #1 is that postischemic injury in those with DF lowers the GDR mainly by depressing the transcapillary hydraulic pressure gradient. GFR (insulin clearance) and its remaining four determinants will be evaluated 1 - 3 hour and 7 days after reperfusion of the Tx. Renal plasma flow (RPF) will be determined initially by Doppler flow meter and again on day 7 by a novel, non-invasive technique based on phase contrast, cine-MRI. Oncotic pressure will be determined by membrane osmometry. Glomeruli obtained by biopsy on each occasion will be subjected to a morphometric analysis and hydrodynamic model of viscous flow to determine filtration surface area (s) and hydraulic permeability (k). A model of ultrafiltration will be used. We seek to confirm that sustained ARF in humans is a consequence of dissipation of the net pressure for ultrafiltration. Hypothesis #2 is that depression in Tx recipients with DF vs. PF is associated with activation of tubulo-glomerular feedback (TFG) and consequent afferent vasoconstriction. The fractional excretion of Li+ will be used as a surrogate for Na+ delivery to the macula densa. Impaired proximal Na+ reabsorption will be related to renovascular resistance and to polarity of proximal tubule cells in the serial biopsies. Cell polarity will be determined from the distribution of Na+/K+- ATPase and various cytoskeletal proteins of the plasma membrane using confocal microscopy. Hypothesis #3 is that enhanced paracellular flow through damaged tubules allows filtrate to leak back into the interstitium, thereby further lowering the clearance of dextrans of graded size to calculate the fraction of filtered insulin that leaks back. This will then be related to structural alterations in denudation of tubular basement membrane and expansion of their interstitium. Finally, for Hypothesis #4, we will conduct a controlled trial of insulin-like growth factor (IGF-1) vs. placebo in all Tx recipients predicted to exhibit DF and ARF by a GFR < 15 ml/min at the 1 - 3 hour study. Rh-IFG-1 in restoring GFR by day 7 will be attributable to regeneration of an insulin-permeable proximal nephron lined by backleak and TGF-mediated afferent constriction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ROSIGLITAZONE VS TELMISARTAN ON THE MODIFICATION OF INSULIN-RESISTANCE CKD
-
批准号:7717920
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2007
-
负责人:BRYAN David MYERS
-
依托单位:
RENAL SENESCENCE AND TRANSPLANTATION
-
批准号:7605190
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2007
-
负责人:BRYAN David MYERS
-
依托单位:
RENAL SENESCENCE AND TRANSPLANTATION
-
批准号:7717860
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2007
-
负责人:BRYAN David MYERS
-
依托单位:
PATHOPHYSIOLOGY OF CHRONIC ALLOGRAFT NEPHROPATHY
-
批准号:7375283
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2005
-
负责人:BRYAN David MYERS
-
依托单位:
COMPENSATORY CHANGES IN RENAL SENESCENCE
-
批准号:7375252
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2005
-
负责人:BRYAN David MYERS
-
依托单位:
RENAL SENESCENCE AND TRANSPLANTATION
-
批准号:7375243
-
项目类别:
-
资助金额:$1.91万
-
财政年份:2005
-
负责人:BRYAN David MYERS
-
依托单位:
RENAL SENESCENCE AND TRANSPLANTATION
-
批准号:7202089
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2004
-
负责人:BRYAN David MYERS
-
依托单位:
COMPENSATORY CHANGES IN RENAL SENESCENCE
-
批准号:7202104
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2004
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:6670378
-
项目类别:
-
资助金额:$39.93万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Pathophysiology of Renal Failure & Renal Artery Stenosis
-
批准号:6980932
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:6916268
-
项目类别:
-
资助金额:$40.91万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
The Glomerular Injury of Pre-Eclampsia
-
批准号:6980886
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:7257256
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:6980980
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:7092016
-
项目类别:
-
资助金额:$47.82万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Compensatory Changes in Renal Senescence
-
批准号:6980982
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
Renal Senescence and Transplantation
-
批准号:6797755
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2003
-
负责人:BRYAN David MYERS
-
依托单位:
DESIGN OF A THERAPEUTIC INTERVENTION IN IGA NEPHROPATHY
-
批准号:6486041
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:BRYAN David MYERS
-
依托单位:
GLOMERULAR INJURY OF PRE-ECLAMPSIA
-
批准号:6486087
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:BRYAN David MYERS
-
依托单位:
RECOMBINANT HUMAN INSULINLIKE GROWTH FACTOR
-
批准号:6486046
-
项目类别:
-
资助金额:$13.47万
-
财政年份:2000
-
负责人:BRYAN David MYERS
-
依托单位:
海外基金